BSEM Nasdaq Journey Advances

Momentum Continues as BioStem Advances Toward Nasdaq👀

July 13, 2026

 *Disseminated on behalf of BioStem Technologies

Momentum Continues as BioStem Advances Toward Nasdaq

Good morning,

BioStem Technologies (OTC: BSEM) has announced the public filing of a Form 10 registration statement with the U.S. Securities and Exchange Commission, marking another important milestone in its planned pursuit of a Nasdaq listing.

Management reaffirmed its strategic decision to pursue a Nasdaq uplisting, noting that becoming an SEC reporting company is expected to strengthen the company's position in the public markets.

According to CEO Jason Matuszewski, completing the registration process is intended to enhance credibility, improve market visibility and liquidity, expand access to capital, and reinforce BioStem's ability to attract exceptional talent as the company continues executing its long-term growth strategy.

The Registration Statement remains subject to SEC review and has not yet been declared effective. Once effective, it will satisfy a required step in the Nasdaq uplisting process.

Until an uplisting occurs, BioStem's shares will continue trading on the OTC market under the ticker symbol BSEM.

BioStem develops, manufactures, and commercializes advanced perinatal tissue allograft solutions and maintains an expanding portfolio of products supported by proprietary processing technologies, growing clinical research initiatives, and a national commercial footprint.

DISCLAIMER: This publication is owned and operated by Sherwood Ventures LLC (“SV”). Full disclaimer: https://bullseyealerts.com/disclaimer/.

NOT INVESTMENT ADVICE: We are a financial publisher, not a registered investment advisor. Content provided is for informational, educational, and promotional purposes only and should not be considered investment advice or a recommendation to buy or sell any security.

*PAID PROMOTION/COMPENSATION DISCLOSURE: SV has received six thousand dollars cash (via Sideways Frequency) for this one day program on 7/13/26 for marketing efforts to increase public awareness of BioStem Technologies, Inc. (BSEM). SV may have also previously been compensated for similar marketing efforts. As SV has received compensation from these companies, these parties have financial interests in the securities referenced. Further, SV and its affiliates may buy, sell, or hold positions in securities mentioned at any time without notice.

RISK WARNING: Investing involves substantial risk. Securities discussed may be highly speculative and volatile. Past performance is not indicative of future results, and you may lose some or all of your investment. Always consult a licensed financial professional before making investment decisions.